Scisparc Ltd
NASDAQ:SPRC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Forvia SE
MIL:1FRVIA
|
FR |
|
H
|
Hibiscus Petroleum Bhd
KLSE:HIBISCS
|
MY |
|
Tongdao Liepin Group
HKEX:6100
|
CN |
|
M
|
Masisa SA
SGO:MASISA
|
CL |
|
A
|
ABIOMED Inc
LSE:0H7S
|
US |
|
Marzetti Co
NASDAQ:MZTI
|
US |
|
Jiangsu Skyray Instrument Co Ltd
SZSE:300165
|
CN |
|
Beijing Lirr High-temperature Materials Co Ltd
SZSE:002392
|
CN |
Scisparc Ltd
Other Current Liabilities
Scisparc Ltd
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Scisparc Ltd
NASDAQ:SPRC
|
Other Current Liabilities
$341k
|
CAGR 3-Years
-7%
|
CAGR 5-Years
103%
|
CAGR 10-Years
28%
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Other Current Liabilities
$22m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
24%
|
CAGR 10-Years
14%
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
Other Current Liabilities
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Other Current Liabilities
$3.4m
|
CAGR 3-Years
14%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Other Current Liabilities
$266k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Pluri Inc
NASDAQ:PLUR
|
Other Current Liabilities
$1.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
Scisparc Ltd
Glance View
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
See Also
What is Scisparc Ltd's Other Current Liabilities?
Other Current Liabilities
341k
USD
Based on the financial report for Dec 31, 2024, Scisparc Ltd's Other Current Liabilities amounts to 341k USD.
What is Scisparc Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
28%
Over the last year, the Other Current Liabilities growth was -40%. The average annual Other Current Liabilities growth rates for Scisparc Ltd have been -7% over the past three years , 103% over the past five years , and 28% over the past ten years .
